COVID-19
Page links we feel
are helpful for you
typical Symptoms
COVID-19
Royal College of Obstetricians and Gynaecologists
COVID-19 Virus Infection and Pregnancy
Information for pregnant women and their families
Coronavirus disease (COVID-19) outbreak
https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Country & Technical Guidance – Coronavirus disease (COVID-19)
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance
Leading health experts from around the world have been meeting at the World Health Organization’s Geneva headquarters to assess the current level of knowledge about the new COVID-19 disease, identify gaps and work together to accelerate and fund priority research needed to help stop this outbreak and prepare for any future outbreaks.
The 2-day forum was convened in line with the WHO R&D Blueprint – a strategy for developing drugs and vaccines before epidemics, and accelerating research and development while they are occurring.
“This outbreak is a test of solidarity — political, financial and scientific. We need to come together to fight a common enemy that does not respect borders, ensure that we have the resources necessary to bring this outbreak to an end and bring our best science to the forefront to find shared answers to shared problems. Research is an integral part of the outbreak response,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “I appreciate the positive response of the research community to join us at short notice and come up with concrete plans and commitment to work together.”
The meeting, hosted in collaboration with GloPID-R (the Global Research Collaboration for Infectious Disease Preparedness) brought together major research funders and over 300 scientists and researchers from a large variety of disciplines. They discussed all aspects of the outbreak and ways to control it including:
- the natural history of the virus, its transmission, and diagnosis;
- animal and environmental research on the origin of the virus, including management measures at the human-animal interface;
- epidemiological studies;
- clinical characterization and management of disease caused by the virus;
- infection prevention and control, including the best ways to protect health care workers;
- research and development for candidate therapeutics and vaccines;
- ethical considerations for research;
- and integration of social sciences into the outbreak response.
“This meeting allowed us to identify urgent priorities for research. As a group of funders we will continue to mobilize, coordinate and align our funding to enable the research needed to tackle this crisis and stop the outbreak, in partnership with WHO,” said Professor Yazdan Yazdanpanah, chair of GloPID-R. “Equitable access – making sure we share data and reach those most in need, in particular those in lower and middle-income countries, is fundamental to this work which must be guided by ethical considerations at all times.”
During the meeting, the more than 300 scientists and researchers participating both in person and virtually agreed on a set of global research priorities. They also outlined mechanisms for continuing scientific interactions and collaborations beyond the meeting which will be coordinated and facilitated by WHO. They worked with research funders to determine how necessary resources can be mobilized so that critical research can start immediately.
The deliberations will form the basis of a research and innovation roadmap charting all the research needed and this will be used by researchers and funders to accelerate the research response.
COVID-19
These Stats are being updated Week by Week
Novel Coronavirus Worldometer Sections:
Age, Sex, Existing Conditions of COVID-19 Cases and Deaths
COVID-19 CORONAVIRUS OUTBREAK
https://www.worldometers.info/coronavirus/
Confirmed Cases and Deaths by Country, Territory, or Conveyance
This page as like the others above are being updated
typical Symptoms
COVID-19 typically causes flu-like symptoms including fever and cough.
In some patients – particularly the elderly and others with other chronic health conditions – these symptoms can develop into pneumonia, with chest tightness, chest pain, and shortness of breath.
It seems to start with a fever, followed by a dry cough.
After a week, it can lead to shortness of breath, with about 20% of patients requiring hospital treatment.
Notably, the COVID-19 infection rarely seems to cause a runny nose, sneezing, or sore throat (these symptoms have been observed in only about 5% of patients). Sore throat, sneezing, and stuffy nose are most often signs of a cold.
Reported illnesses have ranged from people with mild symptoms to people being severely ill and dying.
Symptoms can include:
- Fever
- Cough
- Shortness of breath
https://www.worldometers.info/coronavirus/coronavirus-symptoms/#mild
Coronavirus Incubation Period:
2 – 14 days
The incubation period (time from exposure to the development of symptoms) of the virus is estimated to be between 2 and 14 days based on the following sources:
- The World Health Organization (WHO) reported an incubation period for COVID-19 between 2 and 10 days.
- China’s National Health Commission (NHC) had initially estimated an incubation period from 10 to 14 days.
- The United States’ CDC estimates the incubation period for COVID-19 to be between 2 and 14 days.
- DXY.cn, a leading Chinese online community for physicians and health care professionals, is reporting an incubation period of “3 to 7 days, up to 14 days”.
The estimated range will be most likely narrowed down as more data becomes available.
The incubation period of up to 24 days?
The incubation period has been found to be as long as 24 days (range: 0-24 days; median: 3.0 days) in a study published on February 9.
The WHO said in a press conference on February 10 that:
- a very long incubation period could reflect a double exposure.
- 24 days represented an outlier observation that must be taken into consideration in the context of the main finding of the study.
- WHO is not considering changing recommendations regarding incubation periods.
The incubation period of 5.2 days on average
A Chinese study published in the New England Journal of Medicine on Jan. 30, has found the incubation period to be 5.2 days on average, but it varies greatly among patients. The Chinese team conducting the study said their findings support a 14-day medical observation period for people exposed to the pathogen.Below is an extract of the study findings (highlight added by Worldometer):
https://www.worldometers.info/coronavirus/coronavirus-incubation-period/
